| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO
1 company
Suria Hamza is a President, CEO at ANAB. Recent filings cover 0 purchases and 25 sales. Those positions are worth an estimated $6.1M at current prices.
Our model assigns Suria Hamza a middling insider score of 68/100, based on 5 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +14.1%.
Suria Hamza's largest disclosed position is in ANAB as President, CEO, worth about $6.1M. The recent filings there lean toward selling, a net 279,386 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 36,645 | $35.57 | $1,303,558.53 | -13.4% | -26.7% | -21.2% | |
| Nov 5, 2021 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 20,361 | $35.00 | $712,635.00 | -13.1% | -18.8% | -19.9% | |
| Nov 1, 2021 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 36,646 | $32.31 | $1,184,106.45 | -21.0% | -0.2% | -7.6% | |
| Oct 26, 2021 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 15,993 | $30.00 | $479,790.00 | -19.1% | +4.8% | -7.9% | |
| Jun 10, 2019 | ANAB Anaptysbio, Inc | President, CEO | Sell | 22,428 | $73.76 | $1,654,349.96 | -16.6% | - | - | |
| Jan 14, 2019 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 40,000 | $70.79 | $2,831,531.74 | -35.6% | - | - | |
| Dec 14, 2018 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 41,728 | $69.36 | $2,894,375.08 | -26.6% | - | - | |
| Dec 12, 2018 | ANAB Anaptysbio, Inc | President, CEO | Sale+OE | 65,585 | $71.47 | $4,687,413.22 | -19.4% | - | - |